Precision BioSciences Inc. (NASDAQ: DTIL)
$7.2300
+0.7300 ( +11.06% ) 72.2K
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Market Data
Open
$7.2300
Previous close
$6.5000
Volume
72.2K
Market cap
$56.77M
Day range
$6.6100 - $7.4200
52 week range
$6.4100 - $19.4299
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
10-q | Quarterly Reports | 67 | May 13, 2024 |
8-k | 8K-related | 13 | May 13, 2024 |
8-k | 8K-related | 11 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |